一種設計用于增加短距離反射治療精確性的設備，在2005年10月美國丹佛(CO, USA)舉行的美國治療放射學和腫瘤學學會(ASTRO)年度會議上贏得了好評。

這種設備由Envisioneering醫療科技公司(St. Louis, MO, USA)，叫做TargetScan，能夠為放射腫瘤醫生提供固定探針，以及增強三維(3D)影像掃描，從而增加放置放射源的準確性并減少手術時間。

在ASTRO會議上，醫生檢查了該設備以確認其是否能夠滿足放射腫瘤醫生的需要，包括需要固定探針在拍攝矢狀面和橫斷面圖像的時候以免除移動前列腺，以及精確輸送治療藥物到事先未計劃的目標區域的能力。ASTRO參會人員還與已經在臨床測試過TargetScan系統的放射醫生進行了互動交流，包括華盛頓大學醫學院(St. Louis, MO, USA)的Jeff Michalski醫生和西雅圖前列腺研究院(Washington, USA)的Peter Grimm醫生。

Device Improves Brachytherapy
 
A new device designed to improve the accuracy of brachytherapy treatments won praise at the 2005 annual meeting for the American Society for Therapeutic Radiology and Oncology (ASTRO) in October 2005 in Denver (CO, USA).

Developed by Envisioneering Medical Technologies (St. Louis, MO, USA), TargetScan provides radiation oncologists with a stationary probe and enhanced three-dimensional (3D) imaging acquisition for improved seed-placement accuracy and reduced procedure time.

At the ASTRO meeting, clinicians examined the device intended to address the unmet requirements of radiation oncologists, which include the need for a stationary probe to eliminate prostate movement while obtaining both sagittal and transverse image acquisition and the ability to deliver precise treatments to pre-planned target sites. ASTRO attendees also interacted with radiation oncologists who have clinically tested TargetScan, including Jeff Michalski, M.D., with Washington University School of Medicine in (St. Louis, MO, USA) and Peter Grimm, D.O., of the Seattle Prostate Institute (Washington, USA).